ACCELEWARE LTD (AXE.CA) Stock Fundamental Analysis

TSX-V:AXE • CA00433V1085

0.08 CAD
0 (0%)
Last: Feb 10, 2026, 07:00 PM
Fundamental Rating

0

Overall AXE gets a fundamental rating of 0 out of 10. We evaluated AXE against 67 industry peers in the Software industry. AXE may be in some trouble as it scores bad on both profitability and health. AXE does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year AXE has reported negative net income.
  • AXE had a negative operating cash flow in the past year.
  • AXE had negative earnings in 4 of the past 5 years.
  • AXE had a negative operating cash flow in each of the past 5 years.
AXE.CA Yearly Net Income VS EBIT VS OCF VS FCFAXE.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M -4M

1.2 Ratios

  • With a Return On Assets value of -146.31%, AXE is not doing good in the industry: 79.10% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -146.31%
ROE N/A
ROIC N/A
ROA(3y)83.08%
ROA(5y)23.71%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AXE.CA Yearly ROA, ROE, ROICAXE.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for AXE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AXE.CA Yearly Profit, Operating, Gross MarginsAXE.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

0

2. Health

2.1 Basic Checks

  • AXE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, AXE has about the same amount of shares outstanding.
  • Compared to 5 years ago, AXE has more shares outstanding
  • AXE has a worse debt/assets ratio than last year.
AXE.CA Yearly Shares OutstandingAXE.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
AXE.CA Yearly Total Debt VS Total AssetsAXE.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

2.2 Solvency

  • AXE has an Altman-Z score of -105.09. This is a bad value and indicates that AXE is not financially healthy and even has some risk of bankruptcy.
  • AXE's Altman-Z score of -105.09 is on the low side compared to the rest of the industry. AXE is outperformed by 86.57% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -105.09
ROIC/WACCN/A
WACC10.03%
AXE.CA Yearly LT Debt VS Equity VS FCFAXE.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M -4M -6M

2.3 Liquidity

  • A Current Ratio of 0.13 indicates that AXE may have some problems paying its short term obligations.
  • The Current ratio of AXE (0.13) is worse than 88.06% of its industry peers.
  • A Quick Ratio of 0.13 indicates that AXE may have some problems paying its short term obligations.
  • AXE has a worse Quick ratio (0.13) than 88.06% of its industry peers.
Industry RankSector Rank
Current Ratio 0.13
Quick Ratio 0.13
AXE.CA Yearly Current Assets VS Current LiabilitesAXE.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

2

3. Growth

3.1 Past

  • The earnings per share for AXE have decreased strongly by -144.30% in the last year.
  • Looking at the last year, AXE shows a very negative growth in Revenue. The Revenue has decreased by -22.45% in the last year.
  • Measured over the past years, AXE shows a very strong growth in Revenue. The Revenue has been growing by 29.19% on average per year.
EPS 1Y (TTM)-144.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-163.89%
Revenue 1Y (TTM)-22.45%
Revenue growth 3Y90.85%
Revenue growth 5Y29.19%
Sales Q2Q%-95.73%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AXE.CA Yearly Revenue VS EstimatesAXE.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for AXE. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AXE.CA Price Earnings VS Forward Price EarningsAXE.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • AXE's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 758.35
AXE.CA Per share dataAXE.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.02 -0.04

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • No dividends for AXE!.
Industry RankSector Rank
Dividend Yield 0%

ACCELEWARE LTD

TSX-V:AXE (2/10/2026, 7:00:00 PM)

0.08

0 (0%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-19
Earnings (Next)03-31
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners3.86%
Ins Owner ChangeN/A
Market Cap10.44M
Revenue(TTM)2.60M
Net Income(TTM)-823.60K
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.01
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 758.35
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.02
BVpS-0.04
TBVpS-0.04
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -146.31%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)83.08%
ROA(5y)23.71%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score0
Asset Turnover4.63
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 199.32
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.13
Quick Ratio 0.13
Altman-Z -105.09
F-Score0
WACC10.03%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-144.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-163.89%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-22.45%
Revenue growth 3Y90.85%
Revenue growth 5Y29.19%
Sales Q2Q%-95.73%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-100.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y61.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y61.2%
OCF growth 3YN/A
OCF growth 5YN/A

ACCELEWARE LTD / AXE.CA FAQ

What is the fundamental rating for AXE stock?

ChartMill assigns a fundamental rating of 0 / 10 to AXE.CA.


What is the valuation status for AXE stock?

ChartMill assigns a valuation rating of 0 / 10 to ACCELEWARE LTD (AXE.CA). This can be considered as Overvalued.


How profitable is ACCELEWARE LTD (AXE.CA) stock?

ACCELEWARE LTD (AXE.CA) has a profitability rating of 0 / 10.


How financially healthy is ACCELEWARE LTD?

The financial health rating of ACCELEWARE LTD (AXE.CA) is 0 / 10.